๐Ÿ“– Contents ๐Ÿฆ  Hub ๐Ÿ”ฌ Interactive Lab Chapter 14 ยท Immune Disorders
Microbiology · Chapter 14

Immune Disorders

The immune system is the body's best guard. When it misfires, it turns into one of the body's worst threats. Sometimes it overreacts to something harmless, like pollen or a dose of penicillin, and the response itself does the damage. Sometimes it turns on the body's own tissues. Sometimes it is too weak to defend at all. And sometimes blood or an organ is given on purpose to help, and the immune system attacks that help. This chapter walks through all of those problems. Hypersensitivity. Allergy and anaphylaxis. Autoimmunity. Immunodeficiency. Transfusion and transplant reactions. For each one you will see what it looks like in a real person, and what keeps that person safe.

By the end of this chapter you can

  • Say what hypersensitivity is. Then tell the four types (I to IV) apart by mediator, timing, and mechanism.
  • Explain type I allergy from sensitization through IgE, mast-cell degranulation, and anaphylaxis.
  • Say why epinephrine is the first-line treatment for anaphylaxis, and spot the emergency.
  • Explain how self-tolerance breaks down. Then name common autoimmune diseases and their targets.
  • Tell primary (congenital) from secondary (acquired) immunodeficiency.
  • Walk through the course of HIV/AIDS using CD4 counts and opportunistic infections.
  • Explain ABO and Rh blood typing, and the cause of a hemolytic transfusion reaction.
  • Tell the major kinds of graft apart. Then describe rejection and graft-versus-host disease.

Section 1Hypersensitivity: when defense becomes damage

The four types of hypersensitivity reactions compared
Reference. The four Gell and Coombs types of hypersensitivity — types I, II, and III are antibody-mediated, type IV is cell-mediated. OpenStax Microbiology, CC BY 4.0 (via Wikimedia Commons)

An immune response that harms the host

A healthy immune response protects you. It clears an invader, then it quiets down. A hypersensitivity reaction is not like that. It is an immune response that runs too strong, aims at the wrong thing, or is simply not needed. The response itself injures the body's own tissues. The trigger can be truly dangerous, such as a microbe. It can be harmless, such as pollen, a food, or a drug. It can even be part of the body itself. All hypersensitivities share one feature. The damage comes from the immune system's own activity, not straight from the trigger.

Almost every hypersensitivity needs a first, quiet exposure called sensitization. That first meeting causes no symptoms. The immune system just learns the antigen and builds a stock of antibodies or primed T cells against it. The big reaction comes on a later exposure, when that stock fires. So a drug can go in with no trouble the first time, then cause a violent reaction the second time. "No reaction last time" never means a drug is safe.

The four types (Gell and Coombs)

In the 1960s, Gell and Coombs sorted hypersensitivities into four types. They sorted them by the immune mechanism behind each one. The first three run on antibodies. The fourth runs on T cells. A handy memory aid is ACID. Type I is Anaphylactic, or allergic. Type II is Cytotoxic. Type III is Immune-complex. Type IV is Delayed. Types I to III strike within minutes to hours, because the antibodies are already in place. Type IV takes a day or more, because T cells have to be called to the site.

TypeAlso calledMediatorTimingMechanism & example
IImmediate / allergic / anaphylacticIgE on mast cellsSeconds to minutesAllergen cross-links IgE → mast-cell degranulation. Hay fever, food allergy, anaphylaxis
IICytotoxicIgG / IgM vs. cell-surface antigenMinutes to hoursAntibody binds a cell, marking it for destruction (complement, phagocytes). Hemolytic transfusion reaction, HDN, autoimmune hemolytic anemia
IIIImmune-complexIgG in antigen–antibody complexesHoursSoluble complexes deposit in vessels, joints, kidneys and inflame them. Serum sickness, SLE, some glomerulonephritis
IVDelayed-type / cell-mediatedT cells (no antibody)1–3 daysSensitized T cells release cytokines, recruit macrophages. Contact dermatitis (poison ivy, nickel), TB skin test

Keep the antibody-versus-T-cell split in mind. It explains the speed you see. If someone breaks out in hives within minutes of a bee sting, you are watching type I. If a rash shows up two days after a new skin cream, that slow start points to type IV. Timing is a real clue, not a trivia item.

Where all four show up

Each type maps to a real event. Type I is the drug allergy and the anaphylaxis that has to be treated in seconds. Type II is the mismatched blood transfusion that has to be prevented. Type III sits under lupus flares, and under the joint and kidney damage of immune-complex disease. Type IV is the positive tuberculin skin test that gets read at 48 to 72 hours. It is also the contact dermatitis someone blames on gloves or tape.

Timing tells you the type. A reaction that starts in seconds to minutes points to type I, so be ready for anaphylaxis. One that is delayed by a day or more points to type IV. That single question, "how fast did it come on?", sets the urgency before any lab result comes back.
Interactive Run each of the four hypersensitivity types, watch its mechanism play out, and race the four clocks side by side Open full ↑
Key points
  • Hypersensitivity is an immune response that damages the host's own tissues.
  • Most reactions need a quiet sensitization exposure first. The reaction fires on a later exposure.
  • Types I to III are antibody-mediated and fast. Type IV is T-cell-mediated and delayed 1 to 3 days.
  • Remember ACID: Anaphylactic, Cytotoxic, Immune-complex, Delayed.

Section 2Allergy and anaphylaxis

A mast cell degranulating and releasing histamine in a type I reaction
Reference. Type I hypersensitivity — allergen cross-links IgE on a mast cell, triggering degranulation and release of histamine and other mediators. OpenStax Microbiology, CC BY 4.0 (via Wikimedia Commons)

Sensitization first, reaction later

A type I reaction is what most people mean by "an allergy." It runs in two acts. In sensitization, a first exposure to a harmless allergen is taken up and shown to the immune system. The allergen might be pollen, peanut, penicillin, or bee venom. The immune system answers by making IgE antibody against that one allergen. The IgE then coats mast cells in the tissues and basophils in the blood. Those cells are now armed. Nothing dramatic happens yet. The person feels fine.

On the next exposure, the allergen bridges two IgE molecules sitting side by side on a mast cell. That bridging is cross-linking, and it is the trigger. Within seconds the mast cell goes through degranulation. It dumps stored histamine and other mediators, and it starts building leukotrienes and prostaglandins. Those mediators cause the whole familiar package. Vessels widen, so you see redness, warmth, and falling blood pressure. Vessels leak, so you see swelling and hives. Smooth muscle squeezes, so you get bronchospasm and cramping. Glands pour out fluid, so you get a runny nose and watery eyes.

From a local nuisance to a whole-body emergency

Where the reaction happens decides how serious it is. A localized reaction stays near the point of contact. That is allergic rhinitis (hay fever), hives on one patch of skin, or asthma in the airways. A systemic reaction is anaphylaxis. Mediators pour out body-wide, usually because the allergen got into the bloodstream. An injected drug, an IV contrast agent, a sting, or a swallowed food can all do that. Anaphylaxis is a life-threatening emergency. Vessels widen everywhere, so blood pressure crashes, and that is distributive shock. At the same time the airway swells and the bronchi clamp down, which can shut off breathing within minutes.

FeatureLocalized allergyAnaphylaxis (systemic)
Where mediators actNear contact siteWhole body
Typical signsHives, itching, sneezing, wheezeHives plus hypotension, throat/airway swelling, stridor, wheeze, GI cramps, sense of doom
Main dangerDiscomfortAirway closure and shock — can kill in minutes
First-line treatmentAntihistamine; avoid triggerEpinephrine, IM, immediately

Spotting and treating the emergency

The drug that reverses anaphylaxis is epinephrine. It goes intramuscularly into the outer thigh, and it has to be given at the first sign. Not after antihistamines. Not after a wait-and-see. Epinephrine squeezes blood vessels to bring blood pressure back up. It relaxes airway muscle to open breathing. It also calms mast cells. Antihistamines and corticosteroids help alongside it, but they are far too slow and far too weak to carry the job alone. With the drug, protect the airway and give oxygen. Lay the person flat with the legs raised, unless breathing is easier sitting up. Run IV fluids for the shock. Then watch closely, because a biphasic reaction can return hours later, even after everything looks fine.

Prevention counts just as much. A known allergy has to be checked, banded, and honored at every dose of medicine. The most common cause of a preventable drug reaction is an allergy history that was missed or ignored. Anyone with a severe allergy needs to learn to use an epinephrine auto-injector. They also need to know to call emergency services and go to the hospital even after using it.

Epinephrine first, and fast. In anaphylaxis, epinephrine is the only first-line drug. Give it IM into the side of the thigh, and repeat every 5 to 15 minutes if needed. Antihistamines treat the hives, not the parts that kill, which are the airway and the blood pressure. If it is not clear whether a reaction is "bad enough," give the epinephrine. Holding it back is far riskier than giving it.
Interactive Step through the IgE and mast-cell cascade from first exposure to anaphylaxis, then set the dose and the route and read the blood pressure Open full ↑
Key points
  • Type I allergy is sensitization first. The body makes IgE and arms mast cells. The reaction comes later, when allergen cross-links IgE.
  • Mast-cell degranulation releases histamine. That brings vasodilation, swelling, bronchospasm, and secretions.
  • Anaphylaxis is type I gone body-wide. Airway swelling and distributive shock can be fatal in minutes.
  • Treat anaphylaxis with IM epinephrine right away. Then watch for a biphasic return.

Section 3Autoimmunity: the body against itself

A patient with myasthenia gravis showing drooping eyelids, an autoimmune disease
Reference. Myasthenia gravis — autoantibodies against the acetylcholine receptor cause muscle weakness and drooping eyelids, a classic autoimmune disease. OpenStax Microbiology, CC BY 4.0 (via Wikimedia Commons)

How self-tolerance breaks down

Early in life, the immune system learns to leave the body's own molecules alone. That state is called self-tolerance. Young lymphocytes that react too strongly against self get deleted or shut off before they mature. Autoimmunity is the failure of that screening. Self-reactive T cells, or antibodies called autoantibodies, slip past the controls and attack the body's own tissues. The result is an autoimmune disease. The attack uses the same weapons as any hypersensitivity. Often it is type II, with autoantibodies against targets on a cell surface. Sometimes it is type III, with immune complexes. Sometimes it is type IV, with self-reactive T cells.

Why tolerance fails is usually a mix of things. A genetic risk sets the stage. Many autoimmune diseases run in families and link to certain HLA/MHC types. Then something in the environment pulls the trigger, and that something is often an infection. One well-studied route is molecular mimicry. A microbial antigen looks so much like a human protein that antibodies made against the microbe attack the body too. The classic case is rheumatic fever. Antibodies raised against Streptococcus pyogenes cross-react with heart tissue. Autoimmune diseases also fall more often on women. Many come and go in flares and remissions.

Organ-specific versus systemic disease

It helps to sort these diseases by how much of the body they hit. Organ-specific diseases aim autoantibodies or T cells at a single tissue. The thyroid. The pancreatic islets. The neuromuscular junction. The damage and the symptoms stay focused. Systemic diseases, such as systemic lupus erythematosus, make autoantibodies against parts found all over the body, such as the cell nucleus. So they injure many organs at once. Skin, joints, kidneys, blood, and heart.

DiseaseTargetEffectScope
Graves’ diseaseTSH receptor (stimulating antibody)Overactive thyroid (hyperthyroidism)Organ-specific
Hashimoto thyroiditisThyroid tissueUnderactive thyroid (hypothyroidism)Organ-specific
Type 1 diabetes mellitusPancreatic islet β-cellsNo insulin productionOrgan-specific
Myasthenia gravisAcetylcholine receptorMuscle weakness, ptosisOrgan-specific
Multiple sclerosisCNS myelin sheathNerve conduction failureOrgan-specific (CNS)
Rheumatoid arthritisJoint synoviumSymmetric joint inflammation, deformitySystemic
Systemic lupus erythematosusNuclear antigens (anti-nuclear antibodies)Skin, joints, kidney, blood, heartSystemic

Living with an autoimmune disease

Most autoimmune diseases have no cure. So care aims to hold back the immune attack and manage what it has already damaged. Treatment leans on immunosuppression. That means corticosteroids and other drugs that quiet the immune response. It brings its own hazard. Someone who is deliberately immunosuppressed is also more open to infection, which blurs the line between an autoimmune problem and an immunodeficiency one. Some organ-specific diseases are handled another way. Instead of suppressing anything, you simply replace what was lost. Insulin does that in type 1 diabetes. Thyroid hormone does it in Hashimoto disease.

Immunosuppression cuts both ways. The drugs that calm an autoimmune flare also lower the wall against infection. On high-dose steroids or a biologic, a serious infection can show up with only a muted fever, or with few classic signs at all. So a small change in how someone looks or feels deserves a close second look, and infection precautions matter more, not less.
Interactive Pick any of seven classic autoimmune diseases to see which self-tissue lost tolerance, then watch the attack damage that tissue step by step Open full ↑
Key points
  • Autoimmunity is a loss of self-tolerance. Autoantibodies or self-reactive T cells attack the body.
  • Causes combine genetic risk with an environmental trigger. Molecular mimicry, as in rheumatic fever, is one route.
  • Diseases are organ-specific (Graves, Hashimoto, type 1 diabetes, myasthenia gravis, MS) or systemic (RA, SLE).
  • Care centers on immunosuppression or hormone replacement. Immunosuppression raises infection risk.

Section 4Immunodeficiency and HIV/AIDS

Structure of the human immunodeficiency virus (HIV)
Reference. The human immunodeficiency virus (HIV) — a retrovirus that infects and destroys CD4 helper T cells, the coordinators of the immune response. OpenStax Microbiology, CC BY 4.0 (via Wikimedia Commons)

When defenses are too weak

Hypersensitivity and autoimmunity are the immune system doing too much. Immunodeficiency is it doing too little. Some part of the immune system is missing or not working. So infections that a healthy body would shrug off cannot be cleared. Worse, opportunistic organisms move in. Those are microbes that rarely trouble anyone with a working immune system. Immunodeficiencies split into two groups by where they come from.

Primary immunodeficiencies are congenital. The person is born with a genetic defect in some part of immunity. They run from mild to catastrophic. Selective IgA deficiency is often silent and causes no trouble at all. The most severe is severe combined immunodeficiency (SCID). In SCID, both B cells and T cells are missing or do not work. An affected infant has almost no defense. Without treatment such as a bone-marrow transplant, they do not survive infancy. That is where the "bubble" isolation once used to protect them came from.

Secondary (acquired) immunodeficiencies are far more common. They build up after birth from some outside cause. Malnutrition is the leading cause worldwide. Certain cancers do it too, above all the leukemias and lymphomas. So do chemotherapy and other immunosuppressive drugs, radiation, aging, and viral infection. The most important virus here is HIV. Many people are secondarily immunodeficient because of their own treatment. Anyone on chemotherapy, high-dose steroids, or anti-rejection drugs is in that group.

FeaturePrimary immunodeficiencySecondary immunodeficiency
OriginCongenital (genetic)Acquired after birth
OnsetUsually infancy/childhoodAny age
ExamplesSCID, selective IgA deficiency, DiGeorge syndromeHIV/AIDS, malnutrition, chemotherapy, leukemia, steroids
FrequencyRareCommon — a large share of people in hospital

HIV and AIDS

The human immunodeficiency virus (HIV) is a retrovirus. It targets the one cell that coordinates the whole immune response, the CD4 helper T cell. Over years, HIV infects and destroys those cells. As the CD4 count falls, the immune system loses its conductor, and fighting off infection gets harder and harder. HIV spreads through blood, through sexual contact, and from mother to child in pregnancy, at birth, or through breastfeeding. It does not spread through casual contact.

AIDS stands for acquired immunodeficiency syndrome. It is the advanced stage of HIV infection, and it is defined two ways. Either the CD4 count drops below 200 cells/µL, where normal is roughly 500 to 1,500. Or an AIDS-defining opportunistic illness appears. Those are infections and cancers that a working immune system holds back. The list takes in Pneumocystis jirovecii pneumonia, Candida of the esophagus, widespread tuberculosis, cytomegalovirus, and Kaposi sarcoma. The lower the CD4 count, the wider the range of opportunists that can take hold.

The story is far more hopeful than it once was. Antiretroviral therapy (ART) uses combinations of drugs that block different steps of the viral life cycle. ART can push HIV down to undetectable levels. It protects the CD4 count, stops the slide into AIDS, and makes the virus untransmittable through sex. For many people, HIV is now a long-term condition that can be managed. What matters most is support for adherence to a lifelong drug routine, a close watch for opportunistic infections, and steady use of standard precautions. Those are the same barrier practices that guard against every bloodborne pathogen.

A weak immune system hides infection. Without a full immune response, the classic signs get dulled or go missing. No high fever. No pus. No hot red wound. So a serious infection can look deceptively mild. In someone who is neutropenic or living with HIV, treat even a low fever or a subtle change as possibly serious. Careful hand hygiene and protective precautions save lives here, because their own defenses cannot fill the gap.
Interactive Compare primary and secondary immunodeficiency, then drag the HIV timeline to watch CD4 T cells fall and opportunistic infections take hold, with and without treatment Open full ↑
Key points
  • Immunodeficiency is too little immune function. It opens the door to opportunistic infections.
  • Primary means congenital, as in SCID. Secondary means acquired, as in HIV, malnutrition, chemotherapy, or steroids, and it is far more common.
  • HIV destroys CD4 helper T cells. AIDS means CD4 under 200 cells/µL, or an AIDS-defining opportunistic illness.
  • ART suppresses HIV and protects immunity. Support for adherence and standard precautions go with it.

Section 5Transfusion and transplant reactions

The ABO blood group antigens and antibodies
Reference. The ABO blood groups — each type carries specific surface antigens on its red cells and the opposite antibodies in its plasma. OpenStax Microbiology, CC BY 4.0 (via Wikimedia Commons)

ABO and Rh: the blood you can safely give

Red blood cells carry surface molecules that the immune system reads as antigens. The most important set is the ABO system. Type A cells carry the A antigen. Type B carry B. Type AB carry both. Type O carry neither. Here is the part that matters. Each person naturally makes antibodies against the ABO antigen they lack. A type A person has anti-B antibodies. A type O person has both anti-A and anti-B. That is why blood has to be matched. Transfuse the wrong ABO type and the recipient's antibody attacks the donor red cells, and those cells are destroyed.

A second system, Rh, adds "positive" or "negative." Rh-positive cells carry the D antigen. Rh-negative cells do not. Anti-Rh antibodies behave differently from the ABO ones. They are not present from birth. An Rh-negative person makes them only after being exposed to Rh-positive blood. Type O-negative red cells carry none of these antigens, so O-negative is the emergency universal donor for red cells. Type AB-positive plasma carries no anti-A and no anti-B, so AB-positive is the universal recipient.

Blood typeAntigens on red cellsAntibodies in plasmaCan receive red cells from
AAanti-BA, O
BBanti-AB, O
ABA and BnoneA, B, AB, O (universal recipient)
Ononeanti-A and anti-BO only (universal donor)

When a transfusion goes wrong

An acute hemolytic transfusion reaction is a type II hypersensitivity and a true emergency. It is almost always caused by an ABO mismatch, and that mismatch usually traces back to a clerical or identification error at the bedside. The recipient's antibodies bind the transfused donor cells and destroy them, which is hemolysis. That brings fever, chills, flank or back pain, dark urine, and low blood pressure. It can go on to kidney failure and death. The response has to be instant. Stop the transfusion. Keep the IV line open with saline. Notify the provider and the blood bank. Because these reactions start with mistaken identity, the two-person check of the person and the unit at the bedside is not paperwork. It is the actual guard against a fatal error.

A related problem crosses the placenta. Hemolytic disease of the newborn (HDN) happens when an Rh-negative mother was sensitized to Rh-positive blood in an earlier pregnancy. She makes anti-Rh antibodies. Those antibodies cross into a later Rh-positive fetus and destroy its red cells. It is largely preventable. Giving Rh immune globulin (RhoGAM) to Rh-negative mothers stops the sensitization from ever happening.

Interactive Tap any recipient-and-donor square in the ABO/Rh grid to see if the transfusion is safe and why, then hang a unit and watch the reaction run Open full ↑

Transplants and rejection

Transplanting tissue raises the same problem in a new form. The recipient's immune system reads donor cells as foreign, chiefly by their MHC/HLA molecules, and attacks the graft. How hard it attacks depends on how closely donor and recipient are matched. An autograft moves tissue from one spot on a body to another spot on the same body, as in a skin graft. An isograft goes between identical twins. Neither one is rejected. An allograft goes between two genetically different people of the same species, which is the usual organ transplant. It is rejected unless the immune response is suppressed. A xenograft goes between species, and it faces the strongest rejection of all.

Rejection comes in three tempos. Hyperacute rejection hits within minutes, driven by antibodies that were already there. Acute rejection takes days to weeks and is run by T cells. Chronic rejection takes months to years. To keep an allograft alive, the recipient takes immunosuppressant drugs for life. As always, that trades rejection risk for infection risk. One more danger runs the other way. In a bone-marrow or stem-cell transplant, the immune cells in the graft can attack the recipient's body. That is graft-versus-host disease (GVHD).

Interactive Pick a donor, set the HLA match and the dose of immunosuppressant, and run the graft for ten years to see which rejection tempo takes it Open full ↑
The bedside check is the last line of defense. Nearly every fatal hemolytic transfusion reaction traces back to the right blood going to the wrong person. The two-person check of identity against the blood unit, done at the bedside right before the unit is hung, is the exact step that catches the error. Never let it turn into a rushed formality, and stay close during the first 15 minutes, when a reaction is most likely to show itself.
Key points
  • ABO works on one rule. You make antibodies against the antigen you lack. O-negative is the universal red-cell donor, and AB-positive the universal recipient.
  • An acute hemolytic transfusion reaction is a type II reaction from an ABO mismatch. Stop the transfusion at once.
  • HDN comes from Rh incompatibility, and Rh immune globulin prevents it.
  • Grafts: an autograft or isograft is not rejected, and an allograft needs immunosuppression. GVHD is the graft attacking the host.

The chapter in one breath

  • Hypersensitivity is an immune response that harms the host. The four types differ by mediator and timing. Types I to III use antibody, and type IV uses T cells.
  • Type I allergy runs from sensitization and IgE to mast-cell degranulation. Body-wide release is anaphylaxis, treated with IM epinephrine right away.
  • Autoimmunity is lost self-tolerance. It is either organ-specific, as in Graves, type 1 diabetes, and myasthenia gravis, or systemic, as in RA and SLE.
  • Immunodeficiency is too little immunity. Primary is congenital, such as SCID. Secondary is acquired, such as HIV, chemotherapy, or malnutrition.
  • HIV destroys CD4 T cells. AIDS means CD4 under 200/µL or an opportunistic illness, and ART controls it.
  • ABO/Rh matching prevents the type II hemolytic transfusion reaction. Identification errors are the cause, so the bedside check is the safeguard.
  • Grafts are rejected by how badly they are mismatched. Allografts need lifelong immunosuppression, and GVHD is the graft attacking the host.

ReferenceWords worth knowing

A quick reference for the terms in this chapter. Skim it now, or come back whenever a word trips you up.

Allergen
An otherwise harmless antigen that sets off a type I (allergic) hypersensitivity response.
Allograft
A transplant between two genetically different people of the same species. It is the usual organ transplant, and it needs immunosuppression.
Anaphylaxis
A severe, body-wide type I reaction with airway swelling and distributive shock. It is a life-threatening emergency treated with epinephrine.
Autoantibody
An antibody aimed at the body's own tissues.
Autoimmunity
A failure of self-tolerance in which the immune system attacks the body's own cells and tissues.
CD4 helper T cell
The lymphocyte that coordinates the immune response, and the main target of HIV.
Graft-versus-host disease (GVHD)
A reaction in which transplanted (graft) immune cells attack the recipient's tissues. It is seen with bone-marrow and stem-cell transplants.
Hemolytic disease of the newborn (HDN)
Destruction of a fetus's red cells by maternal anti-Rh antibodies. Rh immune globulin prevents it.
Hemolytic transfusion reaction
A type II reaction from an ABO-mismatched transfusion. The recipient's antibodies destroy the donor red cells.
Hypersensitivity
An exaggerated or misdirected immune response that damages the host's own tissues.
IgE
The antibody class that arms mast cells and basophils and drives type I hypersensitivity.
Immunodeficiency
A weak immune response. It is either primary (congenital) or secondary (acquired).
Mast cell
A tissue cell coated with IgE. It releases histamine and other mediators when it degranulates.
Molecular mimicry
A microbial antigen that looks like a self-protein, so anti-microbe antibodies attack the body too. Rheumatic fever is the classic example.
Opportunistic infection
An infection by a normally harmless microbe that takes hold once host defenses are weakened.
Primary immunodeficiency
A congenital, gene-based defect in immune function, such as SCID.
Rh factor
The D red-cell antigen. Rh-positive cells carry it, and Rh-negative cells do not.
Secondary immunodeficiency
An acquired loss of immune function from an outside cause, such as HIV, malnutrition, drugs, or cancer.
Self-tolerance
The immune system's normal ability to recognize the body's own molecules and leave them alone.
Sensitization
The quiet first exposure in which the immune system builds antibodies or primed cells against an antigen, setting up a later reaction.
Severe combined immunodeficiency (SCID)
A severe primary immunodeficiency with no working B cells and no working T cells.

Check yourself

1. Someone took a drug with no trouble the first time, then reacted badly the second time. Explain the idea that accounts for this.
Sensitization. The first exposure is quiet. The immune system builds antibodies, or primed T cells, against the antigen. The reaction fires only on a later exposure. So "no reaction last time" never means a drug is safe.
2. Which hypersensitivity types are antibody-mediated and which one is cell-mediated, and how does that show up in timing?
Types I, II, and III are antibody-mediated and fast, taking minutes to hours. Type IV is T-cell-mediated and delayed 1 to 3 days. The antibodies are already in place, so they act quickly. Type IV has to recruit T cells to the site, which takes a day or more. That is why it is called delayed-type.
3. Walk through the steps of a type I reaction from first exposure to symptoms.
Sensitization: allergen comes in, IgE is made, and that IgE coats mast cells and basophils. Later exposure: allergen cross-links IgE, the mast cell degranulates, histamine and other mediators pour out, and you get vasodilation, swelling, bronchospasm, and secretions. The symptoms come from the mediators, not from the allergen itself.
4. Hives, throat tightness, wheezing, and falling blood pressure start minutes after an IV antibiotic. What is happening, and what is the first-line treatment?
Anaphylaxis, which is type I gone body-wide. Give epinephrine intramuscularly into the outer thigh right away. Also stop the trigger, protect the airway, give oxygen and IV fluids, and watch for a biphasic reaction. Antihistamines help alongside, but they are not the first-line drug.
5. Why are antihistamines not enough as the main treatment for anaphylaxis?
They are too slow and too weak, and they treat the hives rather than the parts that kill, which are airway swelling and shock. Only epinephrine brings blood pressure back, opens the airway, and calms mast cells fast enough to save a life.
6. Define autoimmunity, then explain molecular mimicry with an example.
Autoimmunity is a loss of self-tolerance in which the immune system attacks the body's own tissues. Molecular mimicry is when a microbial antigen looks like a self-protein, so antibodies against the microbe attack the body too. The classic example is rheumatic fever, where antibodies against Streptococcus pyogenes cross-react with heart tissue.
7. Contrast an organ-specific autoimmune disease with a systemic one, and give an example of each.
An organ-specific disease targets one tissue. Type 1 diabetes attacks pancreatic β-cells, and myasthenia gravis attacks the acetylcholine receptor. A systemic disease targets parts found all over the body. SLE attacks nuclear antigens, which injures skin, joints, kidneys, and more.
8. Tell primary from secondary immunodeficiency, and give an example of each.
Primary is congenital and gene-based, such as SCID, which is there from birth. Secondary is acquired after birth from an outside cause, such as HIV, malnutrition, chemotherapy, or steroids. Secondary is far more common, and many people are secondarily immunodeficient because of their own treatment.
9. What cell does HIV destroy, and how is AIDS defined?
HIV destroys CD4 helper T cells. AIDS means a CD4 count below 200 cells/µL, or the presence of an AIDS-defining opportunistic illness. Losing CD4 cells removes the coordinator of the immune response, which leaves the door open to opportunistic infections.
10. Why can a serious infection look deceptively mild when the immune system is weak, and what does that change about care?
Without a full immune response, the classic signs of high fever, pus, and redness get dulled or go missing, so an infection can hide. Treat even a low fever or a subtle change as possibly serious, and use careful hand hygiene and protective precautions, because their own defenses cannot fill the gap.
11. A transfusion starts, and fever, chills, flank pain, and low blood pressure follow quickly. What is the reaction, what immune type is it, and what is the first action?
An acute hemolytic transfusion reaction, which is a type II hypersensitivity, usually from an ABO mismatch. Stop the transfusion at once, keep the line open with saline, and notify the provider and the blood bank. These reactions come from identification errors, which is why the bedside check exists.
12. Rank an autograft, an allograft, and a xenograft by rejection risk, and explain why an allograft needs immunosuppression.
An autograft, which is self to self, is not rejected. An allograft, between two different people, is rejected without treatment. A xenograft, between species, faces the strongest rejection. An allograft carries foreign MHC/HLA molecules that the recipient's immune system attacks, so lifelong immunosuppressants are needed to keep it, at the cost of higher infection risk.